FIELD: biotechnology.
SUBSTANCE: invention refers to a pharmaceutical composition for treating endothelial dysfunction and/or atherosclerotic vascular disease. Said composition contains peptides consisting of fragments of proteins Transgelin, Actin and Biglycan. Present invention also relates to use of said composition for treating chronic obliterating arterial diseases of lower limbs (COADLL) and erectile dysfunction in males.
EFFECT: invention provides a pharmaceutical composition with high biological activity in the absence of acute and chronic toxicity, carcinogenic, embryotoxic, mutagenic, immunotoxic and teratogenic properties, as well as local irritant and allergenic action.
6 cl, 2 dwg, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BISPECIFIC ANTIBODIES AND THEIR APPLICATIONS | 2022 |
|
RU2821577C2 |
| PROPERDIN ANTIBODIES AND PRODUCTION THEREOF | 2021 |
|
RU2830308C1 |
| ISOLATED MODIFIED CAPSID PROTEIN VPI OF ADENO-ASSOCIATED VIRUS SEROTYPE 5 (AAV5), CAPSID AND VECTOR BASED THEREON | 2021 |
|
RU2820088C1 |
| CHIMERIC CYTOKINE RECEPTORS CARRYING PD-1 ECTODOMAIN | 2020 |
|
RU2828214C2 |
| BCMA-SPECIFIC CHIMERIC ANTIGEN RECEPTORS CONTAINING IL-6 SIGNALLING BLOCKER | 2023 |
|
RU2828294C1 |
| MONOCLONAL ANTIBODIES SPECIFIC TO PROTEIN RUSTICYANIN, AND USE OF ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS | 2024 |
|
RU2823344C1 |
| NUCLEOTIDE SEQUENCE CODING FUSED PROTEIN CONSISTING OF FUNCTIONAL FRAGMENT OF HUMAN IL-1RA AND CONSTANT PART OF HEAVY CHAIN OF HUMAN IgG4 | 2023 |
|
RU2821896C1 |
| RECOMBINANT ANTIGEN PROTEINS AND METHOD FOR DETERMINING THE EPITOPIC SPECIFICITY OF AUTOREACTIVE ANTIBODIES TO INDIVIDUAL FRAGMENTS OF THE EXTRACELLULAR DOMAIN OF HUMAN DESMOGLEIN-3 IN PATIENTS WITH PEMPHIGUS VULGARIS, TEST SYSTEM BASED THEREON | 2021 |
|
RU2770444C1 |
| EXPRESSION VECTOR BASED ON ADENO-ASSOCIATED VIRUS CARRYING RECOMBINANT ANTIBODY GENES AND ITS USE FOR PREVENTION OF DISEASES CAUSED BY INFLUENZA A VIRUS AND SARS-CoV-2 VIRUS | 2023 |
|
RU2817792C1 |
| NUCLEOTIDE SEQUENCE CODING FUSED PROTEIN CONSISTING OF SOLUBLE EXTRACELLULAR FRAGMENT OF HUMAN PDGFRA AND CONSTANT PART OF HEAVY CHAIN OF HUMAN IGG4 | 2023 |
|
RU2821574C1 |
